ACIU Peer Comparison by Performance - AC Immune
ACIU performance peer comparison: per Month, Quarter, Year, Year-To-Date vs Biotechnology
Compare ACIU Performance to other Companies
| Symbol | Market Cap | Perf 1w | Perf 1m | Perf 3m | Perf 12m | Perf 5y | Return 12m vs S&P 500 |
Tech. Rating |
|---|---|---|---|---|---|---|---|---|
| ACIU NASDAQ AC Immune |
325M | -9.91% | -1.36% | 36.0% | -10.2% | -44.8% | -19.7% | -11.1% |
| ABBV NYSE AbbVie |
411B | -1.22% | -1.12% | 10.5% | 41.6% | 173% | 26.6% | 87.0% |
| AMGN NASDAQ Amgen |
181B | 0.02% | 10.8% | 14.3% | 19.7% | 75.8% | 7.01% | 52.5% |
| GILD NASDAQ Gilead Sciences |
155B | -0.17% | 1.53% | 6.0% | 45.2% | 154% | 29.8% | 86.9% |
| VRTX NASDAQ Vertex Pharmaceuticals |
110B | -2.81% | 0.77% | 7.09% | -6.41% | 93.8% | -16.3% | 20.8% |
| REGN NASDAQ Regeneron Pharmaceuticals |
73.0B | 1.12% | 21.8% | 18.9% | -5.06% | 34.8% | -16.4% | -17.4% |
| ALNY NASDAQ Alnylam Pharmaceuticals |
60.0B | -1.80% | -9.25% | -2.73% | 79.2% | 262% | 60.2% | 86.8% |
| ARGX NASDAQ argenx |
55.5B | 3.0% | 8.13% | 39.0% | 55.2% | 241% | 38.8% | 80.9% |
| HLN NYSE Haleon |
44.0B | -3.03% | 2.02% | -3.13% | 3.13% | 34.4% | -7.80% | 46.6% |
| INSM NASDAQ Insmed |
41.2B | 4.55% | 18.9% | 54.2% | 175% | 410% | 146% | 86.3% |
| ONC NASDAQ BeiGene |
38.7B | -5.18% | 9.64% | 12.9% | 79.8% | 27.6% | 60.8% | 67.0% |
| NTRA NASDAQ Natera |
27.7B | 12.4% | 19.6% | 40.4% | 34.4% | 162% | 20.1% | 67.8% |
| 22UA XETRA BioNTech SE |
25.1B | -3.43% | -5.12% | -8.17% | -10.7% | -2.26% | -20.2% | -62.8% |
| BNTX NASDAQ BioNTech SE |
24.7B | -6.65% | -10.2% | -12.9% | -5.06% | -8.95% | -15.1% | -49.0% |
| BIIB NASDAQ Biogen |
24.6B | 2.09% | 14.7% | 21.0% | 7.81% | -30.9% | -3.61% | -39.5% |
| UTHR NASDAQ United Therapeutics |
20.1B | 2.69% | 9.71% | 54.9% | 30.3% | 245% | 16.5% | 65.2% |
| INCY NASDAQ Incyte |
19.9B | -3.46% | 18.1% | 18.1% | 43.2% | 25.0% | 28.1% | 34.4% |
| GMAB NASDAQ Genmab AS |
18.8B | -0.66% | -1.64% | 24.9% | 46.9% | -16.7% | 31.3% | -2.48% |
| BIM PA Biomerieux |
14.8B | -2.40% | -4.95% | -17.6% | 9.22% | -5.76% | -2.35% | 26.9% |
| NBIX NASDAQ Neurocrine Biosciences |
14.4B | -3.60% | -1.66% | 4.32% | 12.7% | 48.5% | 0.78% | 35.1% |
| ROIV NASDAQ Roivant Sciences |
14.3B | -1.41% | 14.3% | 73.0% | 76.4% | 94.9% | 57.7% | 81.5% |
| EXAS NASDAQ EXACT Sciences |
13.2B | 48.6% | 60.5% | 114% | 91.0% | -16.5% | 70.8% | 34.8% |
| ASND NASDAQ Ascendis Pharma AS |
12.6B | 1.50% | 2.11% | 8.69% | 68.5% | 32.2% | 50.6% | 78.5% |
| BBIO NASDAQ BridgeBio Pharma |
12.5B | -0.68% | 14.9% | 32.2% | 180% | 39.2% | 151% | 83.1% |
| RVMD NASDAQ Revolution Medicines |
12.4B | 8.54% | 29.4% | 93.3% | 22.5% | 71.5% | 9.47% | 57.5% |
| SMMT NASDAQ Summit Therapeutics |
12.3B | -9.91% | -17.9% | -36.4% | -11.7% | 274% | -21.0% | 55.1% |
| ERF PA Eurofins Scientific SE |
12.2B | -3.56% | -10.2% | -16.6% | 26.5% | -11.4% | 13.1% | 15.3% |
| IONS NASDAQ Ionis Pharmaceuticals |
12.1B | 4.71% | -0.57% | 70.8% | 107% | 45.5% | 84.7% | 65.2% |
| MDGL NASDAQ Madrigal Pharmaceuticals |
12.0B | 5.28% | 23.2% | 38.4% | 71.0% | 380% | 52.9% | 82.0% |
| EXEL NASDAQ Exelixis |
11.3B | -1.35% | 21.0% | 10.4% | 20.6% | 127% | 7.80% | 80.7% |
| BMRN NASDAQ Biomarin Pharmaceutical |
10.4B | -3.21% | -1.11% | -9.45% | -16.1% | -31.9% | -25.0% | -70.2% |
| MRNA NASDAQ Moderna |
9.75B | -10.4% | -17.9% | -16.9% | -39.5% | -77.9% | -45.9% | -85.9% |
| HALO NASDAQ Halozyme Therapeutics |
8.26B | -3.12% | 3.76% | -3.04% | 50.7% | 72.3% | 34.8% | 51.8% |
| ABVX NASDAQ Abivax American Depositary |
8.19B | 21.8% | 34.3% | 71.0% | 1,287% | 959% | 1,140% | 75.3% |
| ABVX PA Abivax |
8.07B | 20.6% | 36.8% | 82.7% | 1,210% | 365% | 1,071% | 67.8% |
| CYTK NASDAQ Cytokinetics |
8.01B | -3.08% | 6.99% | 70.2% | 27.4% | 295% | 13.9% | 38.2% |
| GRFS NASDAQ Grifols |
7.65B | -3.10% | -11.9% | -17.0% | -0.35% | -52.8% | -10.9% | 14.4% |
| MTSR US Metsera, Common Stock |
7.43B | - | 33.1% | 119% | 292% | 292% | 250% | 91.2% |
| MRUS NASDAQ Merus BV |
7.29B | -0.10% | 1.63% | 49.0% | 124% | 504% | 99.9% | 91.7% |
| NUVL NASDAQ Nuvalent |
6.89B | 14.1% | 10.3% | 47.5% | 18.5% | 476% | 5.92% | 64.1% |
| RYTM NASDAQ Rhythm Pharmaceuticals |
6.63B | 4.97% | -10.4% | 1.99% | 69.6% | 358% | 51.6% | 92.7% |
| RGC NASDAQ Regencell Bioscience |
6.43B | -2.92% | -25.6% | 2.35% | 8,313% | 4,468% | 7,422% | 78.7% |
| PTCT NASDAQ PTC Therapeutics |
6.07B | 2.01% | 11.9% | 56.5% | 82.2% | 22.9% | 62.9% | 59.3% |
| PCVX NASDAQ Vaxcyte |
5.96B | 4.65% | 11.1% | 52.5% | -44.5% | 36.6% | -50.4% | -11.8% |
| KRYS NASDAQ Krystal Biotech |
5.93B | 1.50% | 4.22% | 40.0% | 14.7% | 362% | 2.52% | 61.8% |
| ARWR NASDAQ Arrowhead Pharmaceuticals |
5.70B | -7.41% | -0.99% | 88.6% | 104% | -44.2% | 82.0% | 20.6% |
| LEGN NASDAQ Legend Biotech |
5.43B | -11.2% | -16.4% | -22.7% | -31.4% | -2.96% | -38.7% | -48.8% |
| PTGX NASDAQ Protagonist Therapeutics |
5.20B | 1.15% | 9.75% | 49.7% | 107% | 282% | 85.2% | 89.1% |
| ACLX NASDAQ Arcellx |
5.20B | 2.46% | 3.23% | 25.3% | 2.69% | 433% | -8.19% | 68.4% |
| COGT NASDAQ Cogent Biosciences |
5.19B | 2.57% | 114% | 192% | 282% | 254% | 242% | 63.3% |
| TGTX NASDAQ TG Therapeutics |
4.92B | -1.65% | -13.3% | 7.56% | -2.25% | 1.20% | -12.6% | 38.6% |
| CRSP NASDAQ Crispr Therapeutics |
4.87B | -3.56% | -33.4% | -7.12% | 4.30% | -55.2% | -6.75% | 3.42% |
| ALKS NASDAQ Alkermes |
4.83B | -9.09% | -9.01% | -2.69% | 1.0% | 54.6% | -9.70% | 11.4% |
| KYMR NASDAQ Kymera Therapeutics |
4.58B | 1.57% | 6.83% | 52.6% | 46.7% | 35.1% | 31.2% | 58.5% |
| PRAX NASDAQ Praxis Precision Medicines |
4.45B | -7.86% | -6.27% | 263% | 123% | -68.1% | 99.1% | 45.6% |
| APGE NASDAQ Apogee Therapeutics, Common |
4.43B | 0.64% | 11.3% | 75.9% | 40.7% | 273% | 25.8% | 60.4% |
| NAMS NASDAQ NewAmsterdam Pharma |
4.35B | 3.54% | 0.13% | 55.1% | 88.5% | 249% | 68.5% | 79.7% |
| VKTX NASDAQ Viking Therapeutics |
4.27B | -12.1% | 1.54% | 33.4% | -33.5% | 440% | -40.5% | 41.2% |
| IMVT NASDAQ Immunovant |
4.16B | -0.13% | 18.6% | 53.8% | -12.9% | -53.9% | -22.1% | 16.8% |
| BLTE NASDAQ Belite Bio |
4.08B | -2.87% | 20.8% | 72.2% | 32.3% | 931% | 18.3% | 80.6% |
| ACAD NASDAQ ACADIA Pharmaceuticals |
4.06B | -3.13% | 9.36% | -8.18% | 40.8% | -57.5% | 25.8% | 48.7% |
| CRNX NASDAQ Crinetics Pharmaceuticals |
4.05B | 1.30% | -1.13% | 44.3% | -25.2% | 224% | -33.1% | 35.1% |
| INDV NASDAQ Indivior Ordinary Shares |
4.03B | 6.50% | 30.8% | 31.6% | 200% | 269% | 168% | 82.8% |
| CNTA NASDAQ Centessa Pharmaceuticals |
4.03B | 6.05% | 20.8% | 59.4% | 64.5% | 26.6% | 47.1% | 70.1% |
| LGND NASDAQ Ligand Pharmaceuticals |
3.96B | -1.11% | 6.58% | 28.2% | 78.4% | 270% | 59.5% | 81.9% |
| ADMA NASDAQ ADMA Biologics |
3.70B | 4.20% | 11.4% | -5.43% | -23.4% | 799% | -31.6% | 37.5% |
| CELC NASDAQ Celcuity |
3.65B | 9.30% | 33.2% | 92.7% | 636% | 918% | 558% | 77.3% |
| SRRK NASDAQ Scholar Rock Holding |
3.60B | 26.4% | 36.2% | 10.5% | 36.5% | -8.16% | 22.0% | 40.3% |
| MIRM NASDAQ Mirum Pharmaceuticals |
3.56B | -0.13% | -5.30% | 3.67% | 58.3% | 238% | 41.5% | 91.7% |
| MLYS NASDAQ Mineralys Therapeutics |
3.51B | -5.46% | -5.19% | 170% | 232% | 162% | 197% | 73.5% |
| IRON NASDAQ Disc Medicine |
3.40B | 3.80% | 3.65% | 53.9% | 44.4% | -70.0% | 29.1% | 42.5% |
| CDTX NASDAQ Cidara Therapeutics |
3.33B | 107% | 118% | 238% | 1,352% | 384% | 1,198% | 77.7% |
| RARE NASDAQ Ultragenyx |
3.19B | -5.23% | -9.36% | 6.20% | -32.8% | -72.8% | -39.9% | -54.6% |
| VCYT NASDAQ Veracyte |
3.15B | 2.46% | 11.5% | 38.5% | 4.21% | -20.8% | -6.83% | 11.8% |
| KNSA NASDAQ Kiniksa Pharmaceuticals |
3.13B | 2.98% | 6.41% | 24.9% | 95.6% | 168% | 74.9% | 92.9% |
| XENE NASDAQ Xenon Pharmaceuticals |
3.09B | 0.57% | -7.30% | 6.99% | 2.36% | 267% | -8.48% | 19.4% |
| TVTX NASDAQ Travere Therapeutics |
3.03B | 2.48% | 24.5% | 93.3% | 94.5% | 46.9% | 73.9% | 39.5% |
| GRAL NASDAQ GRAIL |
3.00B | 2.94% | -6.75% | 166% | 468% | 322% | 407% | 91.5% |
| DYN NASDAQ Dyne Therapeutics |
2.94B | 6.85% | 17.8% | 68.1% | -32.9% | 6.06% | -40.0% | 19.3% |
| IDYA NASDAQ Ideaya Biosciences |
2.90B | 4.21% | 8.69% | 36.4% | 29.8% | 162% | 16.1% | 56.4% |
| CGON NASDAQ CG Oncology, Common stock |
2.88B | 7.81% | -6.61% | 59.5% | 26.3% | 9.52% | 12.9% | 15.7% |
| CPRX NASDAQ Catalyst Pharmaceuticals |
2.83B | -1.09% | 8.38% | 12.0% | 7.66% | 562% | -3.75% | 21.1% |
| ARQT NASDAQ Arcutis Biotherapeutics |
2.80B | 19.6% | 30.9% | 73.1% | 168% | 8.54% | 140% | 43.4% |
| VRDN NASDAQ Viridian Therapeutics |
2.77B | 3.44% | 22.3% | 62.5% | 48.9% | 70.4% | 33.1% | 29.7% |
| DNLI NASDAQ Denali Therapeutics |
2.56B | 0.06% | -0.52% | 18.3% | -29.7% | -72.4% | -37.2% | -65.1% |
| AGIO NASDAQ Agios Pharm |
2.55B | -42.2% | -42.4% | -33.3% | -55.0% | -44.2% | -59.8% | -12.6% |
| SLNO NASDAQ Soleno Therapeutics |
2.54B | -5.07% | -31.3% | -34.8% | -18.0% | 53.7% | -26.7% | 61.2% |
| APLS NASDAQ Apellis Pharmaceuticals |
2.51B | -1.36% | -27.8% | -26.5% | -28.9% | -59.2% | -36.5% | -63.9% |
| RCUS NYSE Arcus Biosciences |
2.47B | 7.28% | 21.5% | 110% | 45.2% | -17.6% | 29.8% | -15.2% |
| ZLAB NASDAQ Zai Lab |
2.46B | -6.99% | -29.7% | -39.7% | -23.0% | -80.8% | -31.1% | -40.8% |
| EWTX NASDAQ Edgewise Therapeutics |
2.41B | 8.96% | 44.6% | 60.8% | -30.4% | -25.8% | -37.7% | 8.69% |
| FOLD NASDAQ Amicus Therapeutics |
2.35B | 0.75% | 12.0% | 27.7% | -1.46% | -57.8% | -11.9% | -31.4% |
| NNNN NASDAQ Anbio Biotechnology |
2.32B | 14.1% | -11.9% | -47.4% | 361% | 361% | 329% | 85.7% |
| RXRX NASDAQ Recursion Pharmaceuticals |
2.26B | -11.1% | -42.4% | -19.3% | -36.3% | -87.7% | -43.0% | -72.9% |
| BEAM NASDAQ Beam Therapeutics |
2.20B | -4.89% | -32.7% | 28.3% | -15.9% | -51.5% | -24.8% | -63.3% |
| GLPG AS Galapagos |
2.18B | -2.0% | -10.5% | -2.93% | 6.34% | -74.8% | -4.93% | -14.8% |
| GLPG NASDAQ Galapagos |
2.16B | -3.97% | -12.1% | -4.79% | 17.9% | -75.9% | 5.45% | -2.18% |
| GPCR NASDAQ Structure Therapeutics |
2.12B | -1.89% | 23.2% | 85.0% | 4.98% | 129% | -6.14% | 27.2% |
| IBRX NASDAQ Immunitybio |
2.05B | 1.0% | -17.6% | -10.6% | -58.6% | -74.3% | -63.0% | -75.0% |
| AUPH NASDAQ Aurinia Pharmaceuticals |
2.02B | -0.53% | 27.9% | 26.1% | 83.7% | 8.61% | 64.3% | 59.5% |
| VCEL NASDAQ Vericel Ord |
2.02B | -4.99% | 5.08% | 7.04% | -33.9% | 61.4% | -40.9% | -1.51% |